The most promising is PLX4032, a molecule which blocks the action of the protein produced by a specific mutation of a gene called B-RAF.
最有可能结合的药物是PLX4032，这种分子可阻断由B-RAF等位基因突变后产生的蛋白质的活动。
Roche's vemurafenib attacks advanced melanoma by blocking the mutated form of a gene, B-RAF.
罗氏公司的vemurafenib通过阻断一种突变的基因b - raf攻击晚期黑色素瘤。
应用推荐